BPH Energy Issues 134 Million Shares and Awaits Key Permit Decision

Capital Raise Supports Exploration and MedTech Ambitions

BPH Energy Limited (ASX:BPH) kicked off 2026 with a $1.2 million placement, issuing over 134 million new shares at $0.009 each, sweetened by attaching options exercisable at $0.03. The fresh capital is earmarked primarily for advancing oil and gas exploration and development, alongside funding its AI-driven medical technology investee, Cortical Dynamics. Oakley Capital and 62 Capital steered the placement as joint lead managers, reaping a 6% cash fee and broker options that further align incentives.

This capital injection follows a smaller $542,891 raise from issuing 542.9 million new options to replace expired ones, allowing option holders to maintain exposure to BPH’s evolving portfolio. The new options, priced at $0.001 and exercisable at $0.03, bolster working capital amid ongoing operational demands. Directors remain materially involved, with 58 million performance rights granted to Chairman David Breeze, contingent on a successful extension of the critical PEP11 permit.

PEP11 Permit Extension Decision Remains in Limbo

Advent Energy, in which BPH holds a 35.8% direct stake, continues to grapple with regulatory uncertainty as the Federal Court weighs its judicial review of the Joint Authority’s refusal to extend the PEP11 offshore permit. The hearing, conducted in February before Justice Jackson, concluded with submissions and affidavits, but the decision remains reserved. The outcome is pivotal, given PEP11’s centrality to BPH’s upstream ambitions and the vesting condition for the director performance rights.

Meanwhile, the PEP11 Joint Venture maintains compliance with reporting and rent obligations, but the cloud over permit renewal injects risk into the project’s timeline and viability. This legal uncertainty echoes previous concerns about BPH’s financial performance and strategic direction, as reflected in its half-year loss and recent capital raises. The pending court verdict is a key inflection point for the company’s exploration future and investor confidence Federal Court Verdict on PEP 11.

Onshore Energy Enters Voluntary Administration Amid Operational Headwinds

Onshore Energy Pty Ltd, Advent Energy’s wholly owned subsidiary managing Northern Australia’s EP386 and RL1 permits, has been placed into voluntary administration due to persistent delays from government actions, regulatory changes, and Aboriginal Heritage claims. Administrator Bryan Hughes is assessing the company’s assets and liabilities to determine whether a deed of company arrangement or liquidation is the best path forward.

The uncertainty surrounding Onshore Energy casts doubt on the future development of the RL1 Retention Lease, which includes the Weaber Gas Field. BPH investors should note that no assurance exists regarding RL1’s development or Onshore’s survival as a going concern, highlighting ongoing execution risks in BPH’s onshore portfolio.

Cortical Dynamics Nears Clinical Trials for AI Brain Monitoring Device

Cortical Dynamics, where BPH holds a 16.4% stake, is approaching technical completion of its next-generation BARM 2.0 AI-enhanced brain and pain monitoring product. The system uniquely integrates hypnotic depth and pain response monitoring via EEG and AI, aiming to provide clinicians with real-time anesthesia control and improve surgical outcomes.

Following electrical safety and biocompatibility testing, BARM 2.0 is slated for clinical trials in the USA and the Netherlands, with regulatory submissions to follow. The company’s recent showcase at the Wholesale Emergence Conference in Sydney and a presentation to Mayo Clinic representatives in Melbourne underscore growing investor and industry interest in its technology Advances MedTech and Hydrogen Ventures.

Clean Hydrogen Technologies Advances Pilot Production and Funding Plans

Clean Hydrogen Technologies (CHT), another 16.1% BPH investee, has demonstrated consistent turquoise hydrogen and carbon nanotube composite production at its Nashik, India pilot plant. Its core process emits no CO2 and uses natural gas hydrocarbons as feedstock. CHT is progressing detailed engineering compliant with ASME and Indian standards, preparing to build production facilities targeting industrial markets.

The company is actively engaging with Singaporean GenCos and US fuel cell partners for clean hydrogen supply to data centres and other customers, supported by letters of intent and early-stage MOUs. CHT is also pursuing project-level funding ahead of a potential NASDAQ SPAC listing, though timing and success remain uncertain. These developments position BPH to tap into emerging clean energy markets with scalable technology.

Financial Position and Cash Flow

For the March quarter, BPH reported a net operating cash outflow of $231,000 but ended with $3.6 million in cash and equivalents, providing a runway of approximately 15.5 quarters at current burn rates. Investing activities included loans to related entities totaling $225,000. Related party payments amounted to $280,000, including director remuneration and fees to Grandbridge Limited.

While the cash position appears robust, the company’s reliance on external capital and the pending judicial and operational outcomes inject ongoing uncertainty into its financial outlook. Investors will be watching closely how these elements unfold alongside the progress of Cortical Dynamics’ clinical milestones and Clean Hydrogen Technologies’ funding efforts $0.54 Million New Options.